Cardio-Oncology & Heart Failure: Balancing Cancer Survival and Heart Success

As cancer therapies continue to evolve, the intricate interplay between oncology and cardiology grows ever more complex. This session delves into the dynamic landscape of cardio-oncology and heart failure, emphasizing the delicate equilibrium between cancer survival and cardiac well-being. Experts will explore the shared pathophysiology and risk factors that intertwine cancer and heart failure, the cardiotoxic effects of known and emerging cancer treatments, and the challenges of managing cancer therapy–associated heart failure across Stages A through D. Additionally, this session will address the nuanced considerations of cancer development following heart transplantation, offering insights into surveillance and management strategies.

Agenda

• Moderator - Michel Khouri, MD
• Moderator - Michelle Bloom, MD, FHFSA
• The Cancer-Dilemma: Shared Pathophysiology, Risk Factors & Therapy-Induced Heart Failure - Anne Blaes, MD, MS
• Navigating HF Therapeutics During Cancer Treatment and Survivorship - TBD
• When the Heart Beats Again: Managing Cancer After Heart Transplant - Bhavadharini Ramu, MD, FHFSA
• Panel Discussion